0001209191-15-078381.txt : 20151104
0001209191-15-078381.hdr.sgml : 20151104
20151104160007
ACCESSION NUMBER: 0001209191-15-078381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151102
FILED AS OF DATE: 20151104
DATE AS OF CHANGE: 20151104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSITE VISION INC
CENTRAL INDEX KEY: 0000802724
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943015807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 965 ATLANTIC AVE
STREET 2: --
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 5108658800
MAIL ADDRESS:
STREET 1: 965 ATLANTIC AVE
STREET 2: ---
CITY: ALAMEDA
STATE: CA
ZIP: 94501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yost Anthony J
CENTRAL INDEX KEY: 0001445940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22332
FILM NUMBER: 151196842
MAIL ADDRESS:
STREET 1: C/O INSITE VISION, INC.
STREET 2: 965 ATLANTIC AVENUE
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-02
1
0000802724
INSITE VISION INC
INSV
0001445940
Yost Anthony J
220 3RD STREET
ENCINITAS
CA
92024
1
0
0
0
Stock Option (right to buy)
0.52
2015-11-02
4
D
0
30000
D
2009-09-23
2018-09-23
Common Stock
30000
0
D
Stock Option (right to buy)
0.38
2015-11-02
4
D
0
150000
D
2010-12-16
2019-12-16
Common Stock
150000
0
D
Stock Option (right to buy)
0.33
2015-11-02
4
D
0
150000
0.35
D
2011-12-20
2020-12-20
Common Stock
150000
0
D
Stock Option (right to buy)
0.44
2015-11-02
4
D
0
150000
D
2012-12-14
2021-12-14
Common Stock
150000
0
D
Stock Option (right to buy)
0.32
2015-11-02
4
D
0
150000
0.35
D
2013-12-12
2022-12-12
Common Stock
150000
0
D
Stock Option (right to buy)
0.23
2015-11-02
4
D
0
150000
0.35
D
2014-12-11
2023-12-11
Common Stock
150000
0
D
Stock Option (right to buy)
0.22
2015-11-02
4
D
0
150000
0.35
D
2015-12-10
2024-12-10
Common Stock
150000
0
D
In accordance with the terms of the Agreement and Plan of Merger, dated September 15, 2015, as amended and restated, by and among Thea Acquisition Corp ("Purchaser"), Ranbaxy, Inc. and InSite Vision Incorporated ("Issuer") pursuant to which Purchaser was merged with and into Issuer (the "Merger"), this stock option was cancelled at the effective time of the Merger without consideration because the exercise price of the stock option equaled or exceeded $0.35 per share.
This option was cancelled in connection with the Merger in exchange for a cash payment per share equal to the difference between $0.35 and the exercise price of the option.
/s/ Anthony Yost
2015-11-04